Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Nara

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
American Journal of Veterinary Research|April 1, 1983
Experimental Streptococcus equi infection in the horse: correlation with in vivo and in vitro immune responsesP L Nara, S Krakowka, T E Powers, et al.
American Journal of Veterinary Research|November 1, 1983
Systemic and local intestinal antibody response in dogs given both infective and inactivated canine parvovirusP L Nara, K Winters, J B Rice, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 1998
Stimulation of HIV-1-neutralizing antibodies in simian HIV-IIIB-infected macaquesS Müller, D H Margolin, P L Nara, et al.
Journal of Virology|September 1, 1994
Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120C Y Kang, K Hariharan, P L Nara, et al.
Journal of Virology|June 1, 1991
Blocking of human immunodeficiency virus infection depends on cell density and viral stock ageS P Layne, M J Merges, J L Spouge, et al.
AIDS Research and Human Retroviruses|December 1, 1994
Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individualsK Hariharan, P L Nara, L A Shabazz, et al.
Cancer Research|February 1, 1987
Lipoprotein-associated oncornavirus-inactivating factor in the genus Mus: effects on murine leukemia viruses of laboratory and exotic miceP L Nara, N M Dunlop, W G Robey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytesJ D Ahlers, N Dunlop, D W Alling, et al.
Journal of Virology|November 1, 1993
Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodiesN K Back, L Smit, M Schutten, et al.
Nature|July 19, 1990
HIV requires multiple gp120 molecules for CD4-mediated infectionS P Layne, M J Merges, M Dembo, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
American Journal of Veterinary Research|April 1, 1983
Experimental Streptococcus equi infection in the horse: correlation with in vivo and in vitro immune responsesP L Nara, S Krakowka, T E Powers, et al.
American Journal of Veterinary Research|November 1, 1983
Systemic and local intestinal antibody response in dogs given both infective and inactivated canine parvovirusP L Nara, K Winters, J B Rice, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 1998
Stimulation of HIV-1-neutralizing antibodies in simian HIV-IIIB-infected macaquesS Müller, D H Margolin, P L Nara, et al.
Journal of Virology|September 1, 1994
Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120C Y Kang, K Hariharan, P L Nara, et al.
Journal of Virology|June 1, 1991
Blocking of human immunodeficiency virus infection depends on cell density and viral stock ageS P Layne, M J Merges, J L Spouge, et al.
AIDS Research and Human Retroviruses|December 1, 1994
Analysis of B cell repertoire specific to the neutralizing epitopes of glycoprotein 120 in HIV-infected individualsK Hariharan, P L Nara, L A Shabazz, et al.
Cancer Research|February 1, 1987
Lipoprotein-associated oncornavirus-inactivating factor in the genus Mus: effects on murine leukemia viruses of laboratory and exotic miceP L Nara, N M Dunlop, W G Robey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytesJ D Ahlers, N Dunlop, D W Alling, et al.
Journal of Virology|November 1, 1993
Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodiesN K Back, L Smit, M Schutten, et al.
Nature|July 19, 1990
HIV requires multiple gp120 molecules for CD4-mediated infectionS P Layne, M J Merges, M Dembo, et al.
Pageof 8